NCT03666845View on ClinicalTrials.gov

Plasma Ropivacaine Concentrations After Sciatic Nerve Block in Patients With Chronic Kidney Disease

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

July 21, 2022

Study Completion Date

December 28, 2023

Conditions
Regional Anesthesia MorbidityLocal Anesthetic Drug Adverse Reaction
Interventions
PROCEDURE

Sciatic nerve block

Sciatic nerve block will be performed using ropivacaine (2.5mg/kg) under ultrasound-guidance with nerve stimulator.

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT03666845 - Plasma Ropivacaine Concentrations After Sciatic Nerve Block in Patients With Chronic Kidney Disease | Biotech Hunter | Biotech Hunter